Vulpes lagopus strain Blue_001 chromosome 22, ASM1834538v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Vulpes.
Chromosome-level genome assembly of the Arctic fox (Vulpes lagopus) using PacBio sequencing and Hi-C technology
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM031316.1.\nAssembly name: ASM1834538v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Hebei Normal University of\nScience and Technology on 2021/05/12. The original whole-genome\nshotgun project has the accession JADWOQ000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Hebei Normal University of Science and\n Technology\nAssembly Method :: WTDBG2 v. 2.5\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 121.0x\nSequencing Technology :: PacBio Sequel; Illumina NovaSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vulpes lagopus Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.6\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
A-kinase anchor protein 13-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
A-kinase anchor protein 13-like, transcript variant X3
A-kinase anchor protein 13-like, transcript variant X5
A-kinase anchor protein 13-like, transcript variant X4
A-kinase anchor protein 13-like, transcript variant X10
A-kinase anchor protein 13-like, transcript variant X9
A-kinase anchor protein 13-like, transcript variant X6
A-kinase anchor protein 13-like, transcript variant X2
A-kinase anchor protein 13-like, transcript variant X8
A-kinase anchor protein 13-like, transcript variant X1
A-kinase anchor protein 13-like, transcript variant X7
A-kinase anchor protein 13-like isoform X1
A-kinase anchor protein 13-like isoform X2
uncharacterized protein LOC121480484 isoform X6
uncharacterized protein LOC121480484 isoform X5
uncharacterized protein LOC121480484 isoform X3
uncharacterized protein LOC121480484 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85% coverage of the annotated genomic feature by RNAseq alignments
glycine-rich cell wall structural protein 1.0-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ASNSD1 upstream open reading frame protein
asparagine synthetase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
asparagine synthetase domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
ankyrin and armadillo repeat-containing protein
O-sialoglycoprotein endopeptidase like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial
PMS1 homolog 1, mismatch repair system component, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PMS1 homolog 1, mismatch repair system component, transcript variant X1
ORMDL sphingolipid biosynthesis regulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ORMDL sphingolipid biosynthesis regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ORMDL sphingolipid biosynthesis regulator 1, transcript variant X2
PMS1 homolog 1, mismatch repair system component, transcript variant X6
PMS1 homolog 1, mismatch repair system component, transcript variant X3
PMS1 homolog 1, mismatch repair system component, transcript variant X2
PMS1 homolog 1, mismatch repair system component, transcript variant X4
PMS1 homolog 1, mismatch repair system component, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PMS1 homolog 1, mismatch repair system component, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PMS1 homolog 1, mismatch repair system component, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PMS1 homolog 1, mismatch repair system component, transcript variant X9
PMS1 homolog 1, mismatch repair system component, transcript variant X11
PMS1 homolog 1, mismatch repair system component, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromosome 22 C2orf88 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromosome 22 C2orf88 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 22 C2orf88 homolog, transcript variant X3
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inositol polyphosphate-1-phosphatase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inositol polyphosphate-1-phosphatase, transcript variant X2
inositol polyphosphate-1-phosphatase, transcript variant X3
inositol polyphosphate 1-phosphatase isoform X1
inositol polyphosphate-1-phosphatase, transcript variant X4
inositol polyphosphate 1-phosphatase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
major facilitator superfamily domain containing 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
major facilitator superfamily domain containing 6, transcript variant X5
major facilitator superfamily domain containing 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
major facilitator superfamily domain containing 6, transcript variant X2
major facilitator superfamily domain containing 6, transcript variant X4
major facilitator superfamily domain-containing protein 6 isoform X1
major facilitator superfamily domain-containing protein 6 isoform X2
major facilitator superfamily domain containing 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
major facilitator superfamily domain containing 6, transcript variant X6
major facilitator superfamily domain-containing protein 6 isoform X3
major facilitator superfamily domain-containing protein 6 isoform X4
nuclear envelope integral membrane protein 2, transcript variant X1
nuclear envelope integral membrane protein 2, transcript variant X3
nuclear envelope integral membrane protein 2, transcript variant X2
nuclear envelope integral membrane protein 2 isoform X1
nuclear envelope integral membrane protein 2 isoform X2
nuclear envelope integral membrane protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00601
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
NGFI-A binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NGFI-A binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
ribonucleoside-diphosphate reductase subunit M2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ribonucleoside-diphosphate reductase subunit M2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutaminase kidney isoform, mitochondrial isoform X1
glutaminase kidney isoform, mitochondrial isoform X2
glutaminase kidney isoform, mitochondrial isoform X3
signal transducer and activator of transcription 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
signal transducer and activator of transcription 1-alpha/beta
signal transducer and activator of transcription 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
signal transducer and activator of transcription 4, transcript variant X3
signal transducer and activator of transcription 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
signal transducer and activator of transcription 4 isoform X1
signal transducer and activator of transcription 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
nucleic acid binding protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nucleic acid binding protein 1, transcript variant X4
nucleic acid binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nucleic acid binding protein 1, transcript variant X2
nucleic acid binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein with EGF like and two follistatin like domains 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: stress-induced-phosphoprotein 1-like
solute carrier family 39 member 10, transcript variant X1
solute carrier family 39 member 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 39 member 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain containing 150, transcript variant X1
coiled-coil domain containing 150, transcript variant X3
coiled-coil domain containing 150, transcript variant X5
coiled-coil domain containing 150, transcript variant X6
coiled-coil domain containing 150, transcript variant X7
coiled-coil domain containing 150, transcript variant X4
coiled-coil domain containing 150, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain-containing protein 150 isoform X1
coiled-coil domain-containing protein 150 isoform X3
coiled-coil domain-containing protein 150 isoform X5
coiled-coil domain-containing protein 150 isoform X6
coiled-coil domain-containing protein 150 isoform X7
coiled-coil domain-containing protein 150 isoform X4
coiled-coil domain-containing protein 150 isoform X2
coiled-coil domain containing 150, transcript variant X10
coiled-coil domain containing 150, transcript variant X8
coiled-coil domain-containing protein 150 isoform X8
coiled-coil domain containing 150, transcript variant X9
coiled-coil domain-containing protein 150 isoform X9
coiled-coil domain containing 150, transcript variant X11
coiled-coil domain containing 150, transcript variant X12
coiled-coil domain-containing protein 150 isoform X10
coiled-coil domain-containing protein 150 isoform X11
COORDINATES: nucleotide motif:Rfam:12.0:RF00275
uncharacterized LOC121480668, transcript variant X2
uncharacterized LOC121480668, transcript variant X1
uncharacterized LOC121480669, transcript variant X1
uncharacterized LOC121480669, transcript variant X2
general transcription factor IIIC subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
general transcription factor 3C polypeptide 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 61% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
post-GPI attachment to proteins inositol deacylase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 44, transcript variant X3
ankyrin repeat domain 44, transcript variant X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B isoform X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B isoform X3
uncharacterized LOC121480513, transcript variant X2
uncharacterized LOC121480513, transcript variant X1
ankyrin repeat domain 44, transcript variant X2
ankyrin repeat domain 44, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B isoform X4
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B isoform X2
ankyrin repeat domain 44, transcript variant X5
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
splicing factor 3b subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
splicing factor 3b subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
splicing factor 3b subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
splicing factor 3b subunit 1, transcript variant X4
splicing factor 3b subunit 1, transcript variant X5
coenzyme Q-binding protein COQ10 homolog B, mitochondrial isoform X1
coenzyme Q-binding protein COQ10 homolog B, mitochondrial isoform X2
heat shock protein family D (Hsp60) member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
heat shock protein family D (Hsp60) member 1, transcript variant X1
60 kDa heat shock protein, mitochondrial
MOB-like protein phocein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
MOB-like protein phocein, transcript variant X1
MOB-like protein phocein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
small nucleolar RNA SNORA2/SNORA34 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00410
methionyl-tRNA synthetase 2, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
boule homolog, RNA binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
boule homolog, RNA binding protein, transcript variant X3
boule homolog, RNA binding protein, transcript variant X1
phospholipase C like 1 (inactive), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
inactive phospholipase C-like protein 1 isoform X1
phospholipase C like 1 (inactive), transcript variant X2
inactive phospholipase C-like protein 1 isoform X2
phospholipase C like 1 (inactive), transcript variant X3
inactive phospholipase C-like protein 1 isoform X3
39S ribosomal protein L14, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
basic salivary proline-rich protein 2-like
formiminotransferase cyclodeaminase N-terminal like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: formiminotransferase N-terminal subdomain-containing protein
matrix AAA peptidase interacting protein 1, transcript variant X2
matrix AAA peptidase interacting protein 1, transcript variant X3
matrix AAA peptidase interacting protein 1, transcript variant X1
m-AAA protease-interacting protein 1, mitochondrial
spermatogenesis associated serine rich 2 like, transcript variant X4
spermatogenesis associated serine rich 2 like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spermatogenesis associated serine rich 2 like, transcript variant X5
spermatogenesis associated serine rich 2 like, transcript variant X1
spermatogenesis associated serine rich 2 like, transcript variant X3
spermatogenesis associated serine rich 2 like, transcript variant X2
potassium channel tetramerization domain containing 18, transcript variant X1
potassium channel tetramerization domain containing 18, transcript variant X2
potassium channel tetramerization domain containing 18, transcript variant X3
BTB/POZ domain-containing protein KCTD18
uncharacterized LOC121480794, transcript variant X1
uncharacterized LOC121480794, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
aldehyde oxidase 4-like, transcript variant X2
aldehyde oxidase 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
basic leucine zipper and W2 domains 1, transcript variant X1
basic leucine zipper and W2 domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
basic leucine zipper and W2 domain-containing protein 1 isoform X2
basic leucine zipper and W2 domain-containing protein 1 isoform X1
basic leucine zipper and W2 domains 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
basic leucine zipper and W2 domain-containing protein 1 isoform X3
uncharacterized protein C14orf119 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
NGG1 interacting factor 3 like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NGG1 interacting factor 3 like 1, transcript variant X9
NGG1 interacting factor 3 like 1, transcript variant X4
peptidyl-prolyl cis-trans isomerase-like 3
NGG1 interacting factor 3 like 1, transcript variant X2
NGG1 interacting factor 3 like 1, transcript variant X7
NGG1 interacting factor 3 like 1, transcript variant X11
NGG1 interacting factor 3 like 1, transcript variant X10
NGG1 interacting factor 3 like 1, transcript variant X1
NGG1 interacting factor 3 like 1, transcript variant X8
NGG1 interacting factor 3 like 1, transcript variant X3
NGG1 interacting factor 3 like 1, transcript variant X6
family with sequence similarity 126 member B, transcript variant X8
family with sequence similarity 126 member B, transcript variant X3
family with sequence similarity 126 member B, transcript variant X9
family with sequence similarity 126 member B, transcript variant X1
family with sequence similarity 126 member B, transcript variant X5
family with sequence similarity 126 member B, transcript variant X4
family with sequence similarity 126 member B, transcript variant X7
family with sequence similarity 126 member B, transcript variant X2
family with sequence similarity 126 member B, transcript variant X6
family with sequence similarity 126 member B, transcript variant X10
NADH:ubiquinone oxidoreductase subunit B3
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3
CASP8 and FADD like apoptosis regulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CASP8 and FADD like apoptosis regulator, transcript variant X2
CASP8 and FADD like apoptosis regulator, transcript variant X7
CASP8 and FADD like apoptosis regulator, transcript variant X1
CASP8 and FADD like apoptosis regulator, transcript variant X6
CASP8 and FADD like apoptosis regulator, transcript variant X4
CASP8 and FADD like apoptosis regulator, transcript variant X5
CASP8 and FADD like apoptosis regulator, transcript variant X8
CASP8 and FADD like apoptosis regulator, transcript variant X9
CASP8 and FADD-like apoptosis regulator isoform X1
CASP8 and FADD like apoptosis regulator, transcript variant X10
CASP8 and FADD-like apoptosis regulator isoform X2
flagellum associated containing coiled-coil domains 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
flagellum-associated coiled-coil domain-containing protein 1
trafficking kinesin protein 2, transcript variant X1
trafficking kinesin protein 2, transcript variant X2
trafficking kinesin protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
trafficking kinesin-binding protein 2 isoform X1
trafficking kinesin-binding protein 2 isoform X2
STE20 related adaptor beta, transcript variant X4
STE20 related adaptor beta, transcript variant X5
STE20-related kinase adapter protein beta isoform X2
STE20-related kinase adapter protein beta isoform X3
STE20 related adaptor beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
STE20 related adaptor beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
STE20 related adaptor beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
STE20-related kinase adapter protein beta isoform X1
C2 calcium dependent domain containing 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
C2 calcium dependent domain containing 6, transcript variant X3
C2 calcium dependent domain containing 6, transcript variant X5
C2 calcium dependent domain containing 6, transcript variant X4
C2 calcium dependent domain containing 6, transcript variant X6
C2 calcium dependent domain containing 6, transcript variant X2
C2 calcium dependent domain containing 6, transcript variant X1
C2 calcium-dependent domain-containing protein 6 isoform X3
C2 calcium-dependent domain-containing protein 6 isoform X1
C2 calcium-dependent domain-containing protein 6 isoform X2
transmembrane protein 237, transcript variant X5
transmembrane protein 237, transcript variant X3
transmembrane protein 237, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 237, transcript variant X6
transmembrane protein 237, transcript variant X1
transmembrane protein 237, transcript variant X4
transmembrane protein 237, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
alsin Rho guanine nucleotide exchange factor ALS2, transcript variant X4
alsin Rho guanine nucleotide exchange factor ALS2, transcript variant X3
alsin Rho guanine nucleotide exchange factor ALS2, transcript variant X1
alsin Rho guanine nucleotide exchange factor ALS2, transcript variant X2
alsin Rho guanine nucleotide exchange factor ALS2, transcript variant X5
cyclin dependent kinase 15, transcript variant X1
cyclin dependent kinase 15, transcript variant X2
cyclin dependent kinase 15, transcript variant X3
uncharacterized LOC121480662, transcript variant X3
uncharacterized LOC121480662, transcript variant X2
uncharacterized LOC121480662, transcript variant X1
frizzled class receptor 7, transcript variant X2
frizzled class receptor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein KIAA2012 homolog
NOP58 ribonucleoprotein, transcript variant X1
NOP58 ribonucleoprotein, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00575
COORDINATES: nucleotide motif:Rfam:12.0:RF01192
COORDINATES: nucleotide motif:Rfam:12.0:RF01182
bone morphogenetic protein receptor type 2, transcript variant X1
bone morphogenetic protein receptor type 2, transcript variant X2
bone morphogenetic protein receptor type-2 isoform X1
bone morphogenetic protein receptor type-2 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
family with sequence similarity 117 member B, transcript variant X1
family with sequence similarity 117 member B, transcript variant X2
islet cell autoantigen 1 like, transcript variant X3
islet cell autoantigen 1 like, transcript variant X4
islet cell autoantigen 1 like, transcript variant X2
islet cell autoantigen 1 like, transcript variant X1
islet cell autoantigen 1-like protein isoform X4
islet cell autoantigen 1-like protein isoform X2
islet cell autoantigen 1-like protein isoform X1
islet cell autoantigen 1-like protein isoform X3
uncharacterized LOC121480585, transcript variant X1
uncharacterized LOC121480585, transcript variant X2
WD repeat domain 12, transcript variant X2
WD repeat domain 12, transcript variant X1
WD repeat domain 12, transcript variant X3
calcium responsive transcription factor, transcript variant X3
calcium responsive transcription factor, transcript variant X2
calcium responsive transcription factor, transcript variant X5
calcium responsive transcription factor, transcript variant X4
calcium responsive transcription factor, transcript variant X1
calcium responsive transcription factor, transcript variant X9
calcium responsive transcription factor, transcript variant X6
calcium responsive transcription factor, transcript variant X7
calcium responsive transcription factor, transcript variant X14
calcium responsive transcription factor, transcript variant X8
calcium responsive transcription factor, transcript variant X16
calcium responsive transcription factor, transcript variant X17
calcium responsive transcription factor, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium responsive transcription factor, transcript variant X13
calcium responsive transcription factor, transcript variant X10
calcium responsive transcription factor, transcript variant X12
calcium responsive transcription factor, transcript variant X15
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
calcium-responsive transcription factor isoform X1
calcium-responsive transcription factor isoform X5
calcium-responsive transcription factor isoform X3
calcium-responsive transcription factor isoform X4
calcium-responsive transcription factor isoform X8
calcium-responsive transcription factor isoform X6
calcium-responsive transcription factor isoform X7
calcium-responsive transcription factor isoform X2
neurobeachin like 1, transcript variant X2
neurobeachin like 1, transcript variant X6
neurobeachin like 1, transcript variant X3
neurobeachin like 1, transcript variant X1
neurobeachin like 1, transcript variant X4
neurobeachin like 1, transcript variant X5
neurobeachin like 1, transcript variant X7
cytochrome P450 20A1, transcript variant X2
cytochrome P450 20A1, transcript variant X3
cytochrome P450 20A1, transcript variant X1
cytochrome P450 20A1, transcript variant X5
cytochrome P450 20A1, transcript variant X6
cytochrome P450 20A1, transcript variant X4
abl interactor 2, transcript variant X30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
abl interactor 2, transcript variant X29
abl interactor 2, transcript variant X15
abl interactor 2, transcript variant X16
abl interactor 2, transcript variant X32
abl interactor 2, transcript variant X10
abl interactor 2, transcript variant X34
abl interactor 2, transcript variant X17
abl interactor 2, transcript variant X35
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
abl interactor 2, transcript variant X18
abl interactor 2, transcript variant X31
abl interactor 2, transcript variant X12
abl interactor 2, transcript variant X23
abl interactor 2, transcript variant X24
abl interactor 2, transcript variant X33
abl interactor 2, transcript variant X20
abl interactor 2, transcript variant X14
abl interactor 2, transcript variant X25
abl interactor 2, transcript variant X26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
abl interactor 2, transcript variant X11
abl interactor 2, transcript variant X22
abl interactor 2, transcript variant X27
abl interactor 2, transcript variant X28
abl interactor 2, transcript variant X19
abl interactor 2, transcript variant X13
abl interactor 2, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
60S ribosomal protein L23a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
60S ribosomal protein L23a-like isoform X2
60S ribosomal protein L23a-like, transcript variant X1
60S ribosomal protein L23a-like isoform X1
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1, transcript variant X7
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1, transcript variant X2
ras-associated and pleckstrin homology domains-containing protein 1 isoform X6
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1, transcript variant X4
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1, transcript variant X3
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1, transcript variant X1
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1, transcript variant X5
ras-associated and pleckstrin homology domains-containing protein 1 isoform X4
ras-associated and pleckstrin homology domains-containing protein 1 isoform X3
ras-associated and pleckstrin homology domains-containing protein 1 isoform X2
ras-associated and pleckstrin homology domains-containing protein 1 isoform X1
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1, transcript variant X6
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1, transcript variant X8
ras-associated and pleckstrin homology domains-containing protein 1 isoform X7
ras-associated and pleckstrin homology domains-containing protein 1 isoform X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
T-cell-specific surface glycoprotein CD28
cytotoxic T-lymphocyte associated protein 4
inducible T cell costimulator, transcript variant X1
inducible T cell costimulator, transcript variant X2
inducible T cell costimulator, transcript variant X3
inducible T-cell costimulator isoform X1
inducible T-cell costimulator isoform X2
par-3 family cell polarity regulator beta, transcript variant X5
par-3 family cell polarity regulator beta, transcript variant X6
par-3 family cell polarity regulator beta, transcript variant X1
par-3 family cell polarity regulator beta, transcript variant X3
partitioning defective 3 homolog B isoform X1
partitioning defective 3 homolog B isoform X3
partitioning defective 3 homolog B isoform X5
partitioning defective 3 homolog B isoform X6
par-3 family cell polarity regulator beta, transcript variant X4
par-3 family cell polarity regulator beta, transcript variant X2
partitioning defective 3 homolog B isoform X2
partitioning defective 3 homolog B isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
small nucleolar RNA SNORA62/SNORA6 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00091
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
INO80 complex subunit D, transcript variant X6
INO80 complex subunit D, transcript variant X3
INO80 complex subunit D, transcript variant X1
INO80 complex subunit D, transcript variant X7
INO80 complex subunit D, transcript variant X4
INO80 complex subunit D, transcript variant X5
INO80 complex subunit D, transcript variant X2
uncharacterized LOC121480605, transcript variant X2
uncharacterized LOC121480605, transcript variant X3
uncharacterized LOC121480605, transcript variant X1
NADH:ubiquinone oxidoreductase core subunit S1, transcript variant X1
NADH:ubiquinone oxidoreductase core subunit S1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial
eukaryotic translation elongation factor 1 beta 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00280
COORDINATES: nucleotide motif:Rfam:12.0:RF00403
chemerin chemokine-like receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chemerin chemokine-like receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chemerin chemokine-like receptor 2, transcript variant X2
DBF4-type zinc finger-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase domain 23, transcript variant X1
ADAM metallopeptidase domain 23, transcript variant X3
ADAM metallopeptidase domain 23, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 23 isoform X1
disintegrin and metalloproteinase domain-containing protein 23 isoform X3
disintegrin and metalloproteinase domain-containing protein 23 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
family with sequence similarity 237 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
malate dehydrogenase 1B, transcript variant X2
malate dehydrogenase 1B, transcript variant X4
malate dehydrogenase 1B, transcript variant X1
malate dehydrogenase 1B, transcript variant X3
putative malate dehydrogenase 1B isoform X2
putative malate dehydrogenase 1B isoform X1
putative malate dehydrogenase 1B isoform X3
FAST kinase domain-containing protein 2, mitochondrial
carboxypeptidase O, transcript variant X1
carboxypeptidase O, transcript variant X2
Kruppel like factor 7, transcript variant X3
Kruppel like factor 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Kruppel like factor 7, transcript variant X2
Kruppel like factor 7, transcript variant X1
cAMP responsive element binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cAMP responsive element binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cAMP responsive element binding protein 1, transcript variant X2
cAMP responsive element binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
methyltransferase 21A, HSPA lysine, transcript variant X11
cyclic AMP-responsive element-binding protein 1 isoform X1
cyclic AMP-responsive element-binding protein 1 isoform X2
methyltransferase 21A, HSPA lysine, transcript variant X10
protein N-lysine methyltransferase METTL21A isoform X6
cyclic AMP-responsive element-binding protein 1 isoform X3
methyltransferase 21A, HSPA lysine, transcript variant X7
protein N-lysine methyltransferase METTL21A isoform X3
methyltransferase 21A, HSPA lysine, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methyltransferase 21A, HSPA lysine, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
methyltransferase 21A, HSPA lysine, transcript variant X1
methyltransferase 21A, HSPA lysine, transcript variant X3
protein N-lysine methyltransferase METTL21A isoform X1
methyltransferase 21A, HSPA lysine, transcript variant X6
methyltransferase 21A, HSPA lysine, transcript variant X5
methyltransferase 21A, HSPA lysine, transcript variant X8
methyltransferase 21A, HSPA lysine, transcript variant X9
protein N-lysine methyltransferase METTL21A isoform X5
protein N-lysine methyltransferase METTL21A isoform X4
protein N-lysine methyltransferase METTL21A isoform X2
uncharacterized LOC121480837, transcript variant X1
uncharacterized LOC121480837, transcript variant X2
pleckstrin homology domain containing M3, transcript variant X3
pleckstrin homology domain containing M3, transcript variant X2
pleckstrin homology domain containing M3, transcript variant X1
pleckstrin homology domain-containing family M member 3
gamma-crystallin F, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
gamma-crystallin F, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins
gamma-crystallin C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
gamma-crystallin C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
gamma-crystallin B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
gamma-crystallin B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
gamma-crystallin A, transcript variant X7
gamma-crystallin A, transcript variant X8
gamma-crystallin A, transcript variant X3
gamma-crystallin A, transcript variant X11
gamma-crystallin A, transcript variant X2
gamma-crystallin A, transcript variant X9
gamma-crystallin A, transcript variant X12
gamma-crystallin A, transcript variant X10
gamma-crystallin A, transcript variant X13
gamma-crystallin A, transcript variant X1
gamma-crystallin A, transcript variant X4
gamma-crystallin A, transcript variant X14
gamma-crystallin A, transcript variant X16
gamma-crystallin A, transcript variant X5
gamma-crystallin A, transcript variant X15
gamma-crystallin A, transcript variant X6
gamma-crystallin A, transcript variant X17
uncharacterized protein LOC121480574 isoform X3
uncharacterized protein LOC121480574 isoform X1
uncharacterized protein C2orf80 isoform X2
isocitrate dehydrogenase (NADP(+)) 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
isocitrate dehydrogenase (NADP(+)) 1, transcript variant X2
isocitrate dehydrogenase [NADP] cytoplasmic
phosphoinositide kinase, FYVE-type zinc finger containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53% coverage of the annotated genomic feature by RNAseq alignments
phosphoinositide kinase, FYVE-type zinc finger containing, transcript variant X1
phosphoinositide kinase, FYVE-type zinc finger containing, transcript variant X4
phosphoinositide kinase, FYVE-type zinc finger containing, transcript variant X3
phosphoinositide kinase, FYVE-type zinc finger containing, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
1-phosphatidylinositol 3-phosphate 5-kinase isoform X1
1-phosphatidylinositol 3-phosphate 5-kinase isoform X3
1-phosphatidylinositol 3-phosphate 5-kinase isoform X2
1-phosphatidylinositol 3-phosphate 5-kinase isoform X5
phosphoinositide kinase, FYVE-type zinc finger containing, transcript variant X5
1-phosphatidylinositol 3-phosphate 5-kinase isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins
microtubule associated protein 2, transcript variant X3
microtubule associated protein 2, transcript variant X1
microtubule associated protein 2, transcript variant X5
microtubule associated protein 2, transcript variant X6
microtubule associated protein 2, transcript variant X2
microtubule associated protein 2, transcript variant X8
microtubule associated protein 2, transcript variant X9
microtubule associated protein 2, transcript variant X10
microtubule associated protein 2, transcript variant X7
microtubule associated protein 2, transcript variant X15
microtubule associated protein 2, transcript variant X12
microtubule associated protein 2, transcript variant X13
microtubule associated protein 2, transcript variant X14
microtubule associated protein 2, transcript variant X16
microtubule associated protein 2, transcript variant X18
microtubule associated protein 2, transcript variant X17
microtubule associated protein 2, transcript variant X19
microtubule associated protein 2, transcript variant X4
microtubule-associated protein 2 isoform X1
microtubule-associated protein 2 isoform X4
microtubule-associated protein 2 isoform X5
microtubule-associated protein 2 isoform X9
microtubule-associated protein 2 isoform X6
microtubule-associated protein 2 isoform X2
microtubule-associated protein 2 isoform X10
microtubule-associated protein 2 isoform X3
microtubule-associated protein 2 isoform X7
microtubule-associated protein 2 isoform X11
microtubule-associated protein 2 isoform X12
microtubule-associated protein 2 isoform X13
microtubule-associated protein 2 isoform X14
microtubule-associated protein 2 isoform X15
microtubule-associated protein 2 isoform X16
microtubule associated protein 2, transcript variant X11
microtubule-associated protein 2 isoform X8
unc-80 homolog, NALCN channel complex subunit, transcript variant X3
unc-80 homolog, NALCN channel complex subunit, transcript variant X1
unc-80 homolog, NALCN channel complex subunit, transcript variant X2
unc-80 homolog, NALCN channel complex subunit, transcript variant X4
KAT8 regulatory NSL complex subunit 1 like
KAT8 regulatory NSL complex subunit 1-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
acyl-CoA dehydrogenase long chain, transcript variant X2
acyl-CoA dehydrogenase long chain, transcript variant X1
long-chain specific acyl-CoA dehydrogenase, mitochondrial isoform X2
long-chain specific acyl-CoA dehydrogenase, mitochondrial isoform X1
uncharacterized LOC121480730, transcript variant X3
uncharacterized LOC121480730, transcript variant X6
uncharacterized LOC121480730, transcript variant X5
uncharacterized LOC121480730, transcript variant X4
uncharacterized LOC121480730, transcript variant X2
uncharacterized LOC121480730, transcript variant X1
myosin light chain 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myosin light chain 1, transcript variant X2
myosin light chain 1, transcript variant X1
myosin light chain 1, transcript variant X4
myosin light chain 1/3, skeletal muscle isoform isoform X2
myosin light chain 1/3, skeletal muscle isoform isoform X1
myosin light chain 1/3, skeletal muscle isoform isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: heat shock protein HSP 90-beta-like
carbamoyl-phosphate synthase [ammonia], mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
erb-b2 receptor tyrosine kinase 4, transcript variant X2
erb-b2 receptor tyrosine kinase 4, transcript variant X4
erb-b2 receptor tyrosine kinase 4, transcript variant X1
erb-b2 receptor tyrosine kinase 4, transcript variant X5
erb-b2 receptor tyrosine kinase 4, transcript variant X3
erb-b2 receptor tyrosine kinase 4, transcript variant X6
erb-b2 receptor tyrosine kinase 4, transcript variant X7
receptor tyrosine-protein kinase erbB-4 isoform X2
receptor tyrosine-protein kinase erbB-4 isoform X4
receptor tyrosine-protein kinase erbB-4 isoform X1
receptor tyrosine-protein kinase erbB-4 isoform X5
receptor tyrosine-protein kinase erbB-4 isoform X3
receptor tyrosine-protein kinase erbB-4 isoform X6
receptor tyrosine-protein kinase erbB-4 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
IKAROS family zinc finger 2, transcript variant X4
IKAROS family zinc finger 2, transcript variant X7
IKAROS family zinc finger 2, transcript variant X10
IKAROS family zinc finger 2, transcript variant X9
IKAROS family zinc finger 2, transcript variant X8
IKAROS family zinc finger 2, transcript variant X2
IKAROS family zinc finger 2, transcript variant X1
IKAROS family zinc finger 2, transcript variant X5
IKAROS family zinc finger 2, transcript variant X6
IKAROS family zinc finger 2, transcript variant X3
IKAROS family zinc finger 2, transcript variant X11
uncharacterized LOC121480722, transcript variant X1
uncharacterized LOC121480722, transcript variant X2
sperm associated antigen 16, transcript variant X4
sperm associated antigen 16, transcript variant X3
sperm associated antigen 16, transcript variant X1
sperm associated antigen 16, transcript variant X2
sperm-associated antigen 16 protein isoform X4
sperm-associated antigen 16 protein isoform X1
sperm-associated antigen 16 protein isoform X2
sperm-associated antigen 16 protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
uncharacterized LOC121480656, transcript variant X1
uncharacterized LOC121480656, transcript variant X2
von Willebrand factor C domain containing 2 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
von Willebrand factor C domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ATP binding cassette subfamily A member 12, transcript variant X1
ATP binding cassette subfamily A member 12, transcript variant X2
ATP-binding cassette sub-family A member 12 isoform X1
ATP-binding cassette sub-family A member 12 isoform X2
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
bifunctional purine biosynthesis protein ATIC
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: transmembrane protein 169
X-ray repair cross-complementing protein 5
membrane associated ring-CH-type finger 4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1, transcript variant X5
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
insulin like growth factor binding protein 2, transcript variant X1
insulin-like growth factor-binding protein 2 isoform X1
insulin like growth factor binding protein 2, transcript variant X3
insulin-like growth factor-binding protein 2 isoform X3
insulin like growth factor binding protein 2, transcript variant X2
insulin-like growth factor-binding protein 2 isoform X2
insulin like growth factor binding protein 5
insulin-like growth factor-binding protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121480714, transcript variant X2
uncharacterized LOC121480714, transcript variant X1
uncharacterized LOC121480692, transcript variant X2
uncharacterized LOC121480692, transcript variant X1
RUN and FYVE domain containing 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
RUN and FYVE domain-containing protein 4 isoform X3
RUN and FYVE domain containing 4, transcript variant X1
RUN and FYVE domain containing 4, transcript variant X2
RUN and FYVE domain-containing protein 4 isoform X1
RUN and FYVE domain-containing protein 4 isoform X2
C-X-C chemokine receptor type 2, transcript variant X1
C-X-C chemokine receptor type 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
actin related protein 2/3 complex subunit 2
actin-related protein 2/3 complex subunit 2
angio associated migratory cell protein, transcript variant X2
angio associated migratory cell protein, transcript variant X1
angio-associated migratory cell protein isoform X2
angio-associated migratory cell protein isoform X1
PNKD metallo-beta-lactamase domain containing
transmembrane BAX inhibitor motif containing 1, transcript variant X3
transmembrane BAX inhibitor motif containing 1, transcript variant X2
transmembrane BAX inhibitor motif containing 1, transcript variant X1
transmembrane BAX inhibitor motif containing 1, transcript variant X4
ciliogenesis associated TTC17 interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
ciliogenesis-associated TTC17-interacting protein
natural resistance-associated macrophage protein 1
CTD small phosphatase 1, transcript variant X4
CTD small phosphatase 1, transcript variant X5
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X4
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X5
CTD small phosphatase 1, transcript variant X2
CTD small phosphatase 1, transcript variant X1
CTD small phosphatase 1, transcript variant X3
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X1
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X2
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform X3
ubiquitin specific peptidase 37, transcript variant X8
ubiquitin specific peptidase 37, transcript variant X2
ubiquitin specific peptidase 37, transcript variant X4
ubiquitin specific peptidase 37, transcript variant X6
ubiquitin specific peptidase 37, transcript variant X3
ubiquitin specific peptidase 37, transcript variant X7
ubiquitin specific peptidase 37, transcript variant X1
ubiquitin specific peptidase 37, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 37 isoform X2
ubiquitin carboxyl-terminal hydrolase 37 isoform X1
ubiquitin carboxyl-terminal hydrolase 37 isoform X3
translation machinery associated 7 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
translation machinery-associated protein 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
CCR4-NOT transcription complex subunit 9
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4
zinc finger protein 142, transcript variant X1
zinc finger protein 142, transcript variant X2
zinc finger protein 142, transcript variant X3
mitochondrial chaperone BCS1, transcript variant X3
mitochondrial chaperone BCS1, transcript variant X2
mitochondrial chaperone BCS1, transcript variant X1
ring finger protein 25, transcript variant X2
ring finger protein 25, transcript variant X1
E3 ubiquitin-protein ligase RNF25 isoform X2
E3 ubiquitin-protein ligase RNF25 isoform X1
serine/threonine kinase 36, transcript variant X2
serine/threonine kinase 36, transcript variant X5
serine/threonine kinase 36, transcript variant X3
serine/threonine kinase 36, transcript variant X1
serine/threonine kinase 36, transcript variant X6
serine/threonine kinase 36, transcript variant X4
serine/threonine-protein kinase 36 isoform X1
serine/threonine-protein kinase 36 isoform X2
serine/threonine kinase 36, transcript variant X7
serine/threonine-protein kinase 36 isoform X3
tubulin tyrosine ligase like 4, transcript variant X1
tubulin tyrosine ligase like 4, transcript variant X2
tubulin polyglutamylase TTLL4 isoform X1
tubulin polyglutamylase TTLL4 isoform X2
protein kinase AMP-activated non-catalytic subunit gamma 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein kinase AMP-activated non-catalytic subunit gamma 3, transcript variant X3
protein kinase AMP-activated non-catalytic subunit gamma 3, transcript variant X6
protein kinase AMP-activated non-catalytic subunit gamma 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein kinase AMP-activated non-catalytic subunit gamma 3, transcript variant X1
protein kinase AMP-activated non-catalytic subunit gamma 3, transcript variant X5
5'-AMP-activated protein kinase subunit gamma-3 isoform X3
5'-AMP-activated protein kinase subunit gamma-3 isoform X2
5'-AMP-activated protein kinase subunit gamma-3 isoform X1
5'-AMP-activated protein kinase subunit gamma-3 isoform X4
receptor activity-modifying protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC121480842, transcript variant X2
uncharacterized LOC121480842, transcript variant X1
uncharacterized LOC121480842, transcript variant X3
cyclin dependent kinase 5 regulatory subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
FEV transcription factor, ETS family member
crystallin beta A2, transcript variant X2
crystallin beta A2, transcript variant X1
cilia and flagella associated protein 65
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: cilia- and flagella-associated protein 65
non-homologous end joining factor 1, transcript variant X2
non-homologous end joining factor 1, transcript variant X1
non-homologous end-joining factor 1 isoform X1
non-homologous end-joining factor 1 isoform X2
solute carrier family 23 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 23 member 3, transcript variant X2
solute carrier family 23 member 3, transcript variant X1
solute carrier family 23 member 3 isoform X2
solute carrier family 23 member 3 isoform X3
solute carrier family 23 member 3 isoform X1
cyclin Pas1/PHO80 domain containing 1, transcript variant X1
cyclin Pas1/PHO80 domain containing 1, transcript variant X2
cyclin Pas1/PHO80 domain containing 1, transcript variant X3
zinc finger AN1-type containing 2B, transcript variant X1
zinc finger AN1-type containing 2B, transcript variant X2
AN1-type zinc finger protein 2B isoform X2
AN1-type zinc finger protein 2B isoform X1
ATP binding cassette subfamily B member 6 (Langereis blood group)
ATP-binding cassette sub-family B member 6, mitochondrial
autophagy related 9A, transcript variant X5
autophagy related 9A, transcript variant X2
autophagy related 9A, transcript variant X1
autophagy related 9A, transcript variant X4
autophagy related 9A, transcript variant X3
autophagy related 9A, transcript variant X6
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1, transcript variant X1
ankyrin repeat and zinc finger domain-containing protein 1 isoform X1
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1, transcript variant X2
ankyrin repeat and zinc finger domain-containing protein 1 isoform X2
galactosidase beta 1 like, transcript variant X5
galactosidase beta 1 like, transcript variant X4
galactosidase beta 1 like, transcript variant X2
galactosidase beta 1 like, transcript variant X1
galactosidase beta 1 like, transcript variant X3
serine/threonine kinase 16, transcript variant X2
serine/threonine kinase 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 384 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 383 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member B2, transcript variant X2
DnaJ heat shock protein family (Hsp40) member B2, transcript variant X3
DnaJ heat shock protein family (Hsp40) member B2, transcript variant X4
DnaJ heat shock protein family (Hsp40) member B2, transcript variant X5
DnaJ heat shock protein family (Hsp40) member B2, transcript variant X1
dnaJ homolog subfamily B member 2 isoform X3
dnaJ homolog subfamily B member 2 isoform X2
dnaJ homolog subfamily B member 2 isoform X4
dnaJ homolog subfamily B member 2 isoform X1
protein tyrosine phosphatase receptor type N, transcript variant X1
protein tyrosine phosphatase receptor type N, transcript variant X2
protein tyrosine phosphatase receptor type N, transcript variant X3
receptor-type tyrosine-protein phosphatase-like N isoform X2
receptor-type tyrosine-protein phosphatase-like N isoform X1
receptor-type tyrosine-protein phosphatase-like N isoform X3
aspartyl aminopeptidase, transcript variant X2
aspartyl aminopeptidase, transcript variant X1
aspartyl aminopeptidase, transcript variant X4
aspartyl aminopeptidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC121480781, transcript variant X2
uncharacterized LOC121480781, transcript variant X1
uncharacterized LOC121480781, transcript variant X3
striated muscle enriched protein kinase, transcript variant X2
striated muscle enriched protein kinase, transcript variant X3
striated muscle preferentially expressed protein kinase isoform X2
striated muscle preferentially expressed protein kinase isoform X3
striated muscle enriched protein kinase, transcript variant X6
striated muscle enriched protein kinase, transcript variant X5
striated muscle enriched protein kinase, transcript variant X7
striated muscle preferentially expressed protein kinase isoform X5
striated muscle preferentially expressed protein kinase isoform X6
striated muscle enriched protein kinase, transcript variant X1
striated muscle enriched protein kinase, transcript variant X4
striated muscle enriched protein kinase, transcript variant X8
striated muscle enriched protein kinase, transcript variant X12
striated muscle preferentially expressed protein kinase isoform X1
striated muscle preferentially expressed protein kinase isoform X4
striated muscle preferentially expressed protein kinase isoform X8
striated muscle preferentially expressed protein kinase isoform X9
striated muscle enriched protein kinase, transcript variant X9
striated muscle enriched protein kinase, transcript variant X10
striated muscle enriched protein kinase, transcript variant X11
striated muscle preferentially expressed protein kinase isoform X7
striated muscle preferentially expressed protein kinase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
GDP-mannose pyrophosphorylase A, transcript variant X9
GDP-mannose pyrophosphorylase A, transcript variant X3
GDP-mannose pyrophosphorylase A, transcript variant X4
GDP-mannose pyrophosphorylase A, transcript variant X5
GDP-mannose pyrophosphorylase A, transcript variant X6
GDP-mannose pyrophosphorylase A, transcript variant X1
GDP-mannose pyrophosphorylase A, transcript variant X7
GDP-mannose pyrophosphorylase A, transcript variant X10
GDP-mannose pyrophosphorylase A, transcript variant X2
GDP-mannose pyrophosphorylase A, transcript variant X8
GDP-mannose pyrophosphorylase A, transcript variant X11
mannose-1-phosphate guanyltransferase alpha isoform X1
mannose-1-phosphate guanyltransferase alpha isoform X2
mannose-1-phosphate guanyltransferase alpha isoform X3
acid sensing ion channel subunit family member 4
obscurin like cytoskeletal adaptor 1, transcript variant X2
obscurin like cytoskeletal adaptor 1, transcript variant X1
obscurin like cytoskeletal adaptor 1, transcript variant X3
obscurin like cytoskeletal adaptor 1, transcript variant X4
serine/threonine kinase 11 interacting protein, transcript variant X3
serine/threonine kinase 11 interacting protein, transcript variant X2
serine/threonine kinase 11 interacting protein, transcript variant X1
serine/threonine-protein kinase 11-interacting protein isoform X2
serine/threonine-protein kinase 11-interacting protein isoform X1
uncharacterized LOC121480617, transcript variant X2
uncharacterized LOC121480617, transcript variant X1
solute carrier family 4 member 3, transcript variant X1
solute carrier family 4 member 3, transcript variant X2
solute carrier family 4 member 3, transcript variant X3
solute carrier family 4 member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 4 member 3, transcript variant X5
solute carrier family 4 member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
sphingosine-1-phosphate phosphatase 2, transcript variant X1
sphingosine-1-phosphate phosphatase 2, transcript variant X2
sphingosine-1-phosphate phosphatase 2 isoform X1
sphingosine-1-phosphate phosphatase 2 isoform X2
sphingosine-1-phosphate phosphatase 2, transcript variant X3
sphingosine-1-phosphate phosphatase 2 isoform X3
phenylalanyl-tRNA synthetase subunit beta
monoacylglycerol O-acyltransferase 1, transcript variant X1
monoacylglycerol O-acyltransferase 1, transcript variant X3
monoacylglycerol O-acyltransferase 1, transcript variant X2
monoacylglycerol O-acyltransferase 1, transcript variant X4
2-acylglycerol O-acyltransferase 1 isoform X1
2-acylglycerol O-acyltransferase 1 isoform X2
2-acylglycerol O-acyltransferase 1 isoform X3
acyl-CoA synthetase long chain family member 3, transcript variant X1
acyl-CoA synthetase long chain family member 3, transcript variant X2
potassium voltage-gated channel subfamily E regulatory subunit 4
potassium voltage-gated channel subfamily E member 4
uncharacterized LOC121480491, transcript variant X2
uncharacterized LOC121480491, transcript variant X1
adaptor related protein complex 1 subunit sigma 3
WD repeat and FYVE domain containing 1, transcript variant X2
WD repeat and FYVE domain containing 1, transcript variant X1
WD repeat and FYVE domain-containing protein 1
39S ribosomal protein L44, mitochondrial
serpin family E member 2, transcript variant X1
serpin family E member 2, transcript variant X2
uncharacterized LOC121480713, transcript variant X2
uncharacterized LOC121480713, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00007
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
CLN8 transmembrane ER and ERGIC protein, transcript variant X4
CLN8 transmembrane ER and ERGIC protein, transcript variant X3
CLN8 transmembrane ER and ERGIC protein, transcript variant X2
CLN8 transmembrane ER and ERGIC protein, transcript variant X1
CLN8 transmembrane ER and ERGIC protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments